Christina Isacson is an accomplished Chief Business Officer with a wealth of experience in the biotech and pharmaceutical industries. She has a Ph.D. in Neuroscience from Tufts University School of Medicine and a Bachelor of Science in Biology and Business from McGill University.

Christina has held a variety of senior roles in business development and strategy, including Vice President and Head of Business Development at Magenta Therapeutics, Head of Business Development and Strategy at Edimer Pharmaceuticals, and Interim Head of Business Development and Strategy at Decibel Therapeutics. Christina's business acumen started at Ironwood Pharmaceuticals as a Director of Business Development and progressed through several senior management roles. Currently, she also serves as Principal at Third Rock Ventures. Before her tenure at Magenta, she had a stint as Manager of New Ventures at Boston University and as a consultant at Accelerator.

Christina's expertise includes business development, strategy, and commercialization in the biotech and pharmaceutical industries. She has a strong track record in forging partnerships and deals with industry leaders, driving innovation, and developing successful business strategies. She brings a wealth of knowledge to her roles, having been involved in the commercialization and management of a range of biotech products.